155
Participants
Start Date
April 30, 2013
Primary Completion Date
March 31, 2017
Study Completion Date
May 31, 2017
MRX34
micro RNA therapy
Texas Oncology Dallas, Dallas
UT Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston
Uthscsa/Ctrc, San Antonio
Virginia G. Piper Cancer Center, Scottsdale
Mayo Clinic Arizona, Scottsdale
Severance Hospital, Yonsie University Health System, Seoul
Seoul National University Hospital, Seoul
Samsung Medical Center, Seoul
Asan Medical Center, Seoul
Lead Sponsor
Cancer Prevention Research Institute of Texas
OTHER
Mirna Therapeutics, Inc.
INDUSTRY